ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort

Silveira, Cássia G T; Magnani, Diogo M; Costa, Priscilla R; Avelino-Silva, Vivian I; Ricciardi, Michael J; Timenetsky, Maria do Carmo S T; Goulart, Raphaella; Correia, Carolina A; Marmorato, Mariana P; Ferrari, Lilian; Nakagawa, Zelinda B; Tomiyama, Claudia; Tomiyama, Helena; Kalil, Jorge; Palacios, Ricardo; Precioso, Alexander R; Watkins, David I; Kallás, Esper GUnited States
Frontiers in Immunology2022DOI: 10.3389/fimmu.2022.908398
2阅读
引用收藏
分享

摘要

An effective vaccine against the dengue virus (DENV) should induce a balanced, long-lasting antibody (Ab) response against all four viral serotypes. The burst of plasmablasts in the peripheral blood after vaccination may reflect enriched vaccine-specific Ab secreting cells. Here we characterize the acute plasmablast responses from naïve and DENV-exposed individuals following immunization with the live attenuated tetravalent (LAT) Butantan DENV vaccine (Butantan-DV). The frequency of circulating plasmablasts was determined by flow cytometric analysis of fresh whole blood specimens collected from 40 participants enrolled in the Phase II Butantan-DV clinical trial (NCT01696422) before and after (days 6, 12, 15 and 22) vaccination. We observed a peak in the number of circulating plasmablast at day 15 after vaccination in both the DENV naïve and the DENV-exposed vaccinees. DENV-exposed vaccinees experienced a significantly higher plasmablast expansion. In the DENV-naïve vaccinees, plasmablasts persisted for approximately three weeks longer than among DENV-exposed volunteers. Our findings indicate that the Butantan-DV can induce plasmablast responses in both DENV-naïve and DENV-exposed individuals and demonstrate the influence of pre-existing DENV immunity on Butantan DV-induced B-cell responses.

学科与关键词

关键词
denguedengue infectiondengue vaccinehumoral responseplasmablast
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022
卷期
第 13 卷
页码
908398
DOI
10.3389/fimmu.2022.908398
语言
ENGLISH
期刊等级
2区
成果收录
PUBMED

作者

  • S

    Silveira, Cássia G T (第一作者)

  • M

    Magnani, Diogo M

    department · united states · university of miami miller school of medicine

查看全部 18 位作者收起作者
  • C

    Costa, Priscilla R

  • A

    Avelino-Silva, Vivian I

    department

  • R

    Ricciardi, Michael J

    department · united states · university of miami miller school of medicine

  • T

    Timenetsky, Maria do Carmo S T

  • G

    Goulart, Raphaella

  • C

    Correia, Carolina A

  • M

    Marmorato, Mariana P

  • F

    Ferrari, Lilian

  • N

    Nakagawa, Zelinda B

  • T

    Tomiyama, Claudia

  • T

    Tomiyama, Helena

  • K

    Kalil, Jorge

  • P

    Palacios, Ricardo

  • P

    Precioso, Alexander R

    department

  • W

    Watkins, David I

    department · united states · university of miami miller school of medicine

  • K

    Kallás, Esper G

    department

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417